SCHEMBL828962

SCHEMBL828962

CC(C)(C)[N+]([O-])=Cc1cc[n+]([O-])cc1

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
CASP1 P29466 1/20 0.39
BRCA1 P38398 1/20 0.39
CASP7 P55210 1/20 0.39
HBB P68871 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL244830 0.77 TDP1 (0.59) GAAKMT2AMAPTTDP1ALDH1A1
SCHEMBL6260317 0.77 TDP1 (0.59) GAAKMT2AMAPTTDP1ALDH1A1
SCHEMBL267779 0.77 TDP1 (0.59) GAAKMT2AMAPTTDP1ALDH1A1
SCHEMBL15216491 0.75 FBP1 (0.44) GAAKMT2ATDP1ALDH1A1TSHR
SCHEMBL15216492 0.74 GAA (0.42) GAAKMT2AMAPTTDP1ALDH1A1
SCHEMBL6935466 0.73 GAA (0.55) GAAKMT2AMEN1MAPTTDP1
SCHEMBL8039808 0.73 ALDH1A1 (0.46) GAAKMT2AMEN1MAPTTDP1
SCHEMBL729012 0.73 TDP1 (0.40) GAAKMT2ATDP1ALDH1A1TSHR
SCHEMBL15216500 0.73 ALDH1A1 (0.48) GAAMAPTTDP1ALDH1A1TSHR
SCHEMBL4958358 0.73 MAPT (0.48) GAAKMT2AMEN1MAPTCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 422 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326709-A1 THE MICROWAVE-ASSISTED CATALYTIC AMIDATION OF ORGANIC AMINES WITH CARBOXYLIC ACIDS PURDUE RESEARCH FOUNDATION (US) 2025-10-23 US claimed
EP-4389850-A1 FUNCTIONALIZED FLUORESCENT NANODIAMONDS AND THEIR USE FOR THE DETECTION AND/OR QUANTIFICATION OF BIOLOGICAL FREE RADICALS Wainvam-E (FR) 2024-06-26 EP claimed
EP-2056783-B1 HAIR CARE COMPOSITIONS THAT CAN INCREASE THE APPEARANCE OF THICKER AND FULLER HAIR PROCTER & GAMBLE (US) 2017-11-22 EP claimed
US-8354216-B2 Negative-working imaging elements and methods of use EASTMAN KODAK COMPANY (US) 2013-01-15 US claimed
US-20110230513-A1 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSONS DISEASE PHARMA TWO B LTD. (IL) 2011-09-22 US claimed
EP-2303330-A1 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE Pharma Two B Ltd. (IL) 2011-04-06 EP claimed
WO-2009147681-A1 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE PHARMA TWO B LTD. (IL) 2009-12-10 WO claimed
US-20090170134-A1 BIFUNCTIONAL AND TRIFUNCTIONAL NITRONE SPIN TRAPPING COMPOUNDS AND USES THEREOF MEDICAL COLLEGE OF WISCONSIN, INC. 2009-07-02 US claimed
EP-1865936-A2 METHOD OF REGULATING MAMMALIAN KERATINOUS TISSUE The Procter & Gamble Company (US) 2007-12-19 EP claimed
US-20070203240-A1 Personal care compositions and methods for regulating mammalian hair growth THE PROCTER & GAMBLE COMPANY 2007-08-30 US claimed
WO-1997038683-A1 NITRONE FREE RADICAL TRAP TREATMENT OF DEMENTIA ASSOCIATED WITH AIDS VIRUS (HIV-1) INFECTION OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 1997-10-23 WO claimed
JP-2620413-B2 1997-06-11 JP claimed
US-5622994-A NITRONE DERIVATIVES OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 1997-04-22 US claimed
US-5578617-A Method and compositions for treating age related disorders OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 1996-11-26 US claimed
US-5472687-A A water in oil or oil in water emulsion for treating hair loss ; free of hypotensive agent, side-effect reduction PROCTOR PETER H (US) 1995-12-05 US claimed
EP-0327263-B1 Hair growth stimulation with nitroxide and other radicals PROCTOR PETER H (US) 1994-09-07 EP claimed
EP-0496796-B1 METHOD AND COMPOSITIONS FOR INHIBITION OF DISORDERS ASSOCIATED WITH OXIDATIVE DAMAGE OKLAHOMA MED RES FOUND (US) 1994-08-31 EP claimed
EP-0496796-A1 METHOD AND COMPOSITIONS FOR INHIBITION OF DISORDERS ASSOCIATED WITH OXIDATIVE DAMAGE. OKLAHOMA MED RES FOUND (US) 1992-08-05 EP claimed
WO-1991005552-A1 METHOD AND COMPOSITIONS FOR INHIBITION OF DISORDERS ASSOCIATED WITH OXIDATIVE DAMAGE OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 1991-05-02 WO claimed
WO-1988005653-A1 TOPICAL COMPOSITION FOR STIMULATING HAIR GROWTH WITH STABLE FREE RADICALS PROCTOR PETER H (US) 1988-08-11 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326709-A1 THE MICROWAVE-ASSISTED CATALYTIC AMIDATION OF ORGANIC AMINES WITH CARBOXYLIC ACIDS NAAA, OAT, PAM GAA 165/4885KMT2A 860/4885MEN1 369/4885
US-20090170134-A1 BIFUNCTIONAL AND TRIFUNCTIONAL NITRONE SPIN TRAPPING COMPOUNDS AND USES THEREOF TXN2, DUOX1, TXNRD1 GAA 2860/4885KMT2A 4457/4885MEN1 3813/4885
US-20070203240-A1 Personal care compositions and methods for regulating mammalian hair growth PLOD1, PLOD3, PLOD2 GAA 2698/4885KMT2A 2810/4885MEN1 3011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.